◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksTHC › Revenue

Tenet Healthcare Corporation (THC) Revenue 2006–TTM

DATA UPDATED 2026-09-19

Tenet Healthcare Corporation annual revenue for fiscal TTM was $22.2 billion, an increase of 4.3% from $21.3 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

THC Annual Revenue

Revenue (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$22.2B$21.3B$20.7B$20.5B$19.2B$19.5B$17.6B$18.5B$18.3B$19.2B$19.6B$18.6B$16.6B$11.1B$9.1B$8.7B$8.3B$9.0B$8.6B$8.1B$8.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THC Quarterly Revenue

Revenue (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$6.0B$5.4B$5.5B$5.3B$5.3B$5.2B$5.1B$5.1B$5.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

More THC metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All THC financial statements → Interactive THC charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.